Think cannabinoids. Think dsm-firmenich.

Innovate with confidence in the CBD market.

Unlock the potential of cannabinoids

Interest is building rapidly in the cannabidiol (CBD) space; powered by rising consumer awareness and uptake of the ingredient, and the emergence of new science indicating the potential of CBD potential across a number of important health benefit and therapeutic areas. 

In partnership with pioneers in the CBD market dsm-firmenich has created a platform to deliver the quality, purity and reliability that the nutrition and pharmaceutical industries demand. Leveraging our clinical, regulatory and application expertise, we’re helping customers enter the market early and build a leading position with confidence.

The CBD market is full of promise. Let’s discover this ingredient’s innovation potential, together.

Explore the potential of CBD

Expand the research behind CBD health benefits and claims

Develop next generation CBD-based solutions

Young scientist working on microscope in laboratory
Cannabinoid actives for pharmaceuticals

We’re passionate about pioneering the next frontier in medicine – one that’s fueled by cannabinoid research and development. As an end-to-end partner to our customers, we offer a unique innovation platform powered by expert services. Designed to enhance the odds of therapeutic breakthroughs and streamline development pathways in the cannabinoid space, we’re enabling our customers to unlock new treatment possibilities and convenience for patients worldwide.

Discover our high-quality cannabidiol (CBD) pharma API portfolio, as well as the technical, clinical and regulatory expertise you need to navigate the ever-evolving cannabinoid market and expand into new geographies with confidence.

Smiling young woman taking medication at home
Discover CBtru® - a pioneering CBD drug intermediate enabling oral solid dosage forms with optimized bioavailability.

dsm-firmenich has developed CBtru®, a premium formulated CBD drug intermediate and patented solution, that presents several exciting opportunities for patients, healthcare professionals, and manufacturers of pharmaceutical products.

Your partner for CBD innovation

dsm-firmenich is at the forefront of innovation in the rapidly evolving CBD space. As a reliable purpose-led partner, dsm-firmenich offers a broad portfolio of science-backed products and customized solutions powered by expert services that are uniquely aimed at supporting CBD innovation in the pharmaceutical market. This takes more than ingredients; it takes a partner.

Connect with one of our experts today to explore the exciting potential of CBD.

end to end partner image
Related articles
  • From patient trust to emerging evidence: Expert insights behind CBD and chronic pain management
    From patient trust to emerging evidence: Expert insights behind CBD and chronic pain management

    Explore the latest research on CBD and pain relief, including highlights from patient insights, pre-clinical and clinical studies.

  • Supercharge your odds of scientific success with the dsm-firmenich CBD API sampling program
    Supercharge your odds of scientific success with the dsm-firmenich CBD API sampling program

    Learn more about dsm-firmenich’s CBD sampling program for early-stage cannabinoid research and development.

  • How is CBtru®, a novel drug product intermediate, pioneering patient-friendly CBD-based therapies? An expert view
    How is CBtru®, a novel drug product intermediate, pioneering patient-friendly CBD-based therapies? An expert view

    In our Ask-the-Expert, we ask ‘Is our formulated CBtru® drug product intermediate the future of CBD innovation in the pharma market’?

How can we help you?

  • New product concept

    Got a notion for your next project or breakthrough innovation? Let’s put our heads together.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.